S. Colman
Covance (Australia)(AU)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Heart Failure Treatment and Management, Antiplatelet Therapy and Cardiovascular Diseases, Acute Ischemic Stroke Management, Hormonal Regulation and Hypertension
Most-Cited Works
- → The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition(2003)139 cited
- → Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease(2005)79 cited
- → Once‐daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double‐blind, randomized, paroxetine‐controlled, non‐inferiority trial in China, Korea, Taiwan and Brazil(2007)51 cited
- → Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease(2005)46 cited
- → Soluble Vascular Cell Adhesion Molecule 1 and N-terminal Pro–B-Type Natriuretic Peptide in Predicting Ischemic Stroke in Patients With Cerebrovascular Disease(2005)45 cited
- → Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease(2004)40 cited
- → Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease(2007)9 cited
- → Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease(2007)8 cited
- Acute phase results from STORM, a multicountry observational study of bipolar disorder treatment and outcomes.(2007)
- Perindopril-based blood pressure lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or TIA(2005)